Close
4

Seqens Seqens

X

Find Regorafenib manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)

0

INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

0

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

SERVICES

0

Looking for 755037-03-7 / Regorafenib API manufacturers, exporters & distributors?

Regorafenib manufacturers, exporters & distributors 1

82

PharmaCompass offers a list of Regorafenib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Regorafenib manufacturer or Regorafenib supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Regorafenib manufacturer or Regorafenib supplier.

PharmaCompass also assists you with knowing the Regorafenib API Price utilized in the formulation of products. Regorafenib API Price is not always fixed or binding as the Regorafenib Price is obtained through a variety of data sources. The Regorafenib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Regorafenib

Synonyms

755037-03-7, Bay 73-4506, Stivarga, 4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)-3-fluorophenoxy)-n-methylpicolinamide, Regorafenibum, Regorafenib (bay 73-4506)

Cas Number

755037-03-7

Unique Ingredient Identifier (UNII)

24T2A1DOYB

About Regorafenib

Regorafenib is the anhydrous form of regorafenib, an orally bioavailable small molecule with potential antiangiogenic and antineoplastic activities. Regorafenib binds to and inhibits vascular endothelial growth factor receptors (VEGFRs) 2 and 3, and Ret, Kit, PDGFR and Raf kinases, which may result in the inhibition of tumor angiogenesis and tumor cell proliferation. VEGFRs are receptor tyrosine kinases that play important roles in tumor angiogenesis; the receptor tyrosine kinases RET, KIT, and PDGFR, and the serine/threonine-specific Raf kinase are involved in tumor cell signaling.

Stivarga Manufacturers

A Stivarga manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Stivarga, including repackagers and relabelers. The FDA regulates Stivarga manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Stivarga API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Stivarga manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Stivarga Suppliers

A Stivarga supplier is an individual or a company that provides Stivarga active pharmaceutical ingredient (API) or Stivarga finished formulations upon request. The Stivarga suppliers may include Stivarga API manufacturers, exporters, distributors and traders.

click here to find a list of Stivarga suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Stivarga USDMF

A Stivarga DMF (Drug Master File) is a document detailing the whole manufacturing process of Stivarga active pharmaceutical ingredient (API) in detail. Different forms of Stivarga DMFs exist exist since differing nations have different regulations, such as Stivarga USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Stivarga DMF submitted to regulatory agencies in the US is known as a USDMF. Stivarga USDMF includes data on Stivarga's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Stivarga USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Stivarga suppliers with USDMF on PharmaCompass.

Stivarga KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Stivarga Drug Master File in Korea (Stivarga KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Stivarga. The MFDS reviews the Stivarga KDMF as part of the drug registration process and uses the information provided in the Stivarga KDMF to evaluate the safety and efficacy of the drug.

After submitting a Stivarga KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Stivarga API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Stivarga suppliers with KDMF on PharmaCompass.

Stivarga WC

A Stivarga written confirmation (Stivarga WC) is an official document issued by a regulatory agency to a Stivarga manufacturer, verifying that the manufacturing facility of a Stivarga active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Stivarga APIs or Stivarga finished pharmaceutical products to another nation, regulatory agencies frequently require a Stivarga WC (written confirmation) as part of the regulatory process.

click here to find a list of Stivarga suppliers with Written Confirmation (WC) on PharmaCompass.

Stivarga NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Stivarga as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Stivarga API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Stivarga as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Stivarga and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Stivarga NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Stivarga suppliers with NDC on PharmaCompass.

Stivarga GMP

Stivarga Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Stivarga GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Stivarga GMP manufacturer or Stivarga GMP API supplier for your needs.

Stivarga CoA

A Stivarga CoA (Certificate of Analysis) is a formal document that attests to Stivarga's compliance with Stivarga specifications and serves as a tool for batch-level quality control.

Stivarga CoA mostly includes findings from lab analyses of a specific batch. For each Stivarga CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Stivarga may be tested according to a variety of international standards, such as European Pharmacopoeia (Stivarga EP), Stivarga JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Stivarga USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY